In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapy.

about

DNA damage in leukocytes after internal ex-vivo irradiation of blood with the α-emitter Ra-223.Radium and other alpha emitters in prostate cancer

P2860

Q48042018-4729109B-8C5B-4767-BD04-0C451D3DDB39 Q57112384-478DC38F-315F-41B4-9432-7315468A7E7C

P2860

In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapy.

Item

http://www.wikidata.org/entity/Q38696649

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

In Vitro comparison of 213Bi- ...... receptor radionuclide therapy.

@en

type

Item

label

In Vitro comparison of 213Bi- ...... receptor radionuclide therapy.

@en

prefLabel

In Vitro comparison of 213Bi- ...... receptor radionuclide therapy.

@en

P1476

In Vitro comparison of 213Bi- ...... receptor radionuclide therapy

@en

P2093

Alfred Morgenstern

http://www.w3.org/2001/XMLSchema#string

Erik de Blois

http://www.w3.org/2001/XMLSchema#string

Frank Bruchertseifer

http://www.w3.org/2001/XMLSchema#string

Marion de Jong

http://www.w3.org/2001/XMLSchema#string

Mark Konijnenberg

http://www.w3.org/2001/XMLSchema#string

Wouter Breeman

http://www.w3.org/2001/XMLSchema#string

P2860

Counting colonies of clonogenic assays by using densitometric software

In vitro characterization of somatostatin receptors in the human thymus and effects of somatostatin and octreotide on cultured thymic epithelial cells

Somatostatin analogues for receptor targeted photodynamic therapy

Radiation-induced cell death mechanisms.

Bismuth-213 and actinium-225 -- generator performance and evolving therapeutic applications of two generator-derived alpha-emitting radioisotopes.

The potential and hurdles of targeted alpha therapy - clinical trials and beyond.

DNA double strand breaks as predictor of efficacy of the alpha-particle emitter Ac-225 and the electron emitter Lu-177 for somatostatin receptor targeted radiotherapy.

²¹³Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience

Influence of tumour size on the efficacy of targeted alpha therapy with (213)Bi-[DOTA(0),Tyr(3)]-octreotate

Dosimetry in Peptide radionuclide receptor therapy: a review.

P304

e0181473

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0181473

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ho Sze Chan

P577

2017-07-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28732021

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

P932

5521788

http://www.w3.org/2001/XMLSchema#string

In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapy.

about

P2860

P2860

In Vitro comparison of 213Bi- and 177Lu-radiation for peptide receptor radionuclide therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932